3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
3
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Colorectal Neoplasms
13
Carcinoma, Hepatocellular
7
Neoplasms
3
Liver Neoplasms
2
Glioblastoma
2
Gastrointestinal Stromal Tumors
2
Colonic Neoplasms
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Recurrence
1
Rectal Neoplasms
1
Piebaldism
1
Patient Compliance
1
Pathologic Complete Response
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Microsatellite Stable Metastatic Colorectal Cancer
1
Meningioma
1
Melanoma
1
MCRC
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Liver Metastases
1
Leiomyosarcoma
1
Interventions
Temozolomide
6
Cyclophosphamide
5
cabozantinib
4
Vincristine
4
fludarabine
3
Radiotherapy
3
Irinotecan
3
liposomal doxorubicin
2
irinotecan sucrosofate
2
Zoledronic Acid
2
Topotecan
2
Specimen Handling
2
PM 01183
2
Ifosfamide
2
Etoposide
2
Eflornithine
2
Drug Therapy
2
Doxorubicin
2
trilaciclib
1
trifluridine tipiracil drug combination
1
talazoparib
1
silmitasertib
1
romiplostim
1
regorafenib
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
naxitamab
1
fluzoparib
1
fludarabine phosphate
1
X-Rays
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Sarcoma, Ewing
×
regorafenib
×
Clear all
NCT04055220
2026-02-17
REGOSTA
Centre Leon Berard
Phase NA
Recruiting
168 enrolled